Reciprocal Regulation of Akt and Oct4 Promotes the Self-Renewal and Survival of Embryonal Carcinoma Cells

Molecular Cell

Volumn 48, Issue 4, 2012, Pages 627-640

  Lin, Yuanji ^a,b   Yang, Ying ^a   Li, Weihua ^e   Chen, Qi ^a   Li, Jie ^a   Pan, Xiao ^b   Zhou, Lina ^b   Liu, Changwei ^b,f   Chen, Chunsong ^a   He, Jianqin ^a   Cao, Hongcui ^a   Yao, Hangping ^a   Zheng, Li ^f   Xu, Xiaowei ^e   Xia, Zongping ^c   Ren, Jiangtao ^d   Xiao, Lei ^d   Li, Lanjuan ^a   Shen, Binghui ^b,f   Zhou, Honglin ^e   Wang, Ying Jie ^a   more..

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN AKT1; PROTEIN KINASE B; THREONINE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CELL FATE; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; ECTODERM; EMBRYONAL CARCINOMA; HUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONAL CARCINOMA STEM CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84870388822     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.08.030     Document Type: Article

References (55)

1. Ambrosetti D.C., Basilico C., Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 1997, 17:6321-6329.
2. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 2005, 33:1526-1530.
3. Armstrong L., Hughes O., Yung S., Hyslop L., Stewart R., Wappler I., Peters H., Walter T., Stojkovic P., Evans J., et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 2006, 15:1894-1913.
4. Astigiano S., Damonte P., Fossati S., Boni L., Barbieri O. Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. Differentiation 2005, 73:484-490.
5. Bleau A.M., Hambardzumyan D., Ozawa T., Fomchenko E.I., Huse J.T., Brennan C.W., Holland E.C. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009, 4:226-235.
6. Blelloch R.H., Hochedlinger K., Yamada Y., Brennan C., Kim M., Mintz B., Chin L., Jaenisch R. Nuclear cloning of embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 2004, 101:13985-13990.
7. Boiani M., Schöler H.R. Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 2005, 6:872-884.
8. Brumbaugh J., Hou Z., Russell J.D., Howden S.E., Yu P., Ledvina A.R., Coon J.J., Thomson J.A. Phosphorylation regulates human OCT4. Proc. Natl. Acad. Sci. USA 2012, 109:7162-7168.
9. Campbell P.A., Perez-Iratxeta C., Andrade-Navarro M.A., Rudnicki M.A. Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE 2007, 2:e553. 10.1371/journal.pone.0000553.
10. Carnero A. The PKB/AKT pathway in cancer. Curr. Pharm. Des. 2010, 16:34-44.
11. Chaerkady R., Kerr C.L., Kandasamy K., Marimuthu A., Gearhart J.D., Pandey A. Comparative proteomics of human embryonic stem cells and embryonal carcinoma cells. Proteomics 2010, 10:1359-1373.
12. Chang C.C., Shieh G.S., Wu P., Lin C.C., Shiau A.L., Wu C.L. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res. 2008, 68:6281-6291.
13. Chew J.L., Loh Y.H., Zhang W., Chen X., Tam W.L., Yeap L.S., Li P., Ang Y.S., Lim B., Robson P., Ng H.H. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 2005, 25:6031-6046.
14. Chiou S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., Chang H.T., Chen Y.S., Lin T.W., Hsu H.S., Wu C.W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70:10433-10444.
15. Dubrovska A., Kim S., Salamone R.J., Walker J.R., Maira S.M., García-Echeverría C., Schultz P.G., Reddy V.A. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc. Natl. Acad. Sci. USA 2009, 106:268-273.
16. Eyler C.E., Foo W.C., LaFiura K.M., McLendon R.E., Hjelmeland A.B., Rich J.N. Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 2008, 26:3027-3036.
17. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nat. Med. 2009, 15:1010-1012.
18. Hochedlinger K., Yamada Y., Beard C., Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
19. Jang H., Kim T.W., Yoon S., Choi S.Y., Kang T.W., Kim S.Y., Kwon Y.W., Cho E.J., Youn H.D. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012, 11:62-74.
20. Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J., Adjaye J. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS ONE 2010, 5:e10709. 10.1371/journal.pone.0010709.
21. Kang J., Shakya A., Tantin D. Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem. Sci. 2009, 34:491-499.
22. Korkaya H., Paulson A., Charafe-Jauffret E., Ginestier C., Brown M., Dutcher J., Clouthier S.G., Wicha M.S. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol. 2009, 7:e1000121. 10.1371/journal.pbio.1000121.
23. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., Nakatsuji N., Tada T. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 2005, 25:2475-2485.
24. Li J., Zhou B.P. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49. 10.1186/1471-2407-11-49.
25. Liu Y., Shin S., Zeng X., Zhan M., Gonzalez R., Mueller F.J., Schwartz C.M., Xue H., Li H., Baker S.C., et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev. Biol. 2006, 6:20. 10.1186/1471-213X-6-20.
26. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
27. Martelli A.M., Evangelisti C., Follo M.Y., Ramazzotti G., Fini M., Giardino R., Manzoli L., McCubrey J.A., Cocco L. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr. Med. Chem. 2011, 18:2715-2726.
28. Mathieu J., Zhang Z., Zhou W., Wang A.J., Heddleston J.M., Pinna C.M., Hubaud A., Stadler B., Choi M., Bar M., et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 2011, 71:4640-4652.
29. Ng H.H., Surani M.A. The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 2011, 13:490-496.
30. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
31. Pan G., Qin B., Liu N., Schöler H.R., Pei D. Identification of a nuclear localization signal in OCT4 and generation of a dominant negative mutant by its ablation. J. Biol. Chem. 2004, 279:37013-37020.
32. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3:895-902.
33. Pardo M., Lang B., Yu L., Prosser H., Bradley A., Babu M.M., Choudhary J. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010, 6:382-395.
34. Peng S., Maihle N.J., Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010, 29:2153-2159.
35. Reményi A., Schöler H.R., Wilmanns M. Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 2004, 11:812-815.
36. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
37. Saxe J.P., Tomilin A., Schöler H.R., Plath K., Huang J. Post-translational regulation of Oct4 transcriptional activity. PLoS ONE 2009, 4:e4467. 10.1371/journal.pone.0004467.
38. Sell S., Pierce G.B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 1994, 70:6-22.
39. Sharif T., Auger C., Bronner C., Alhosin M., Klein T., Etienne-Selloum N., Schini-Kerth V.B., Fuhrmann G. Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell. Invest. New Drugs 2011, 29:239-247.
40. Silván U., Díez-Torre A., Arluzea J., Andrade R., Silió M., Aréchaga J. Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology. Differentiation 2009, 78:159-168.
41. Singh A.M., Reynolds D., Cliff T., Ohtsuka S., Mattheyses A.L., Sun Y., Menendez L., Kulik M., Dalton S. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012, 10:312-326.
42. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 2003, 100:13350-13355.
43. Swaney D.L., Wenger C.D., Thomson J.A., Coon J.J. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2009, 106:995-1000.
44. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
45. Thomson M., Liu S.J., Zou L.N., Smith Z., Meissner A., Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011, 145:875-889.
46. van den Berg D.L., Snoek T., Mullin N.P., Yates A., Bezstarosti K., Demmers J., Chambers I., Poot R.A. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 2010, 6:369-381.
47. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2:489-501.
48. Wang X.Q., Ongkeko W.M., Chen L., Yang Z.F., Lu P., Chen K.K., Lopez J.P., Poon R.T., Fan S.T. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 2010, 52:528-539.
49. Wang Z., Oron E., Nelson B., Razis S., Ivanova N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012, 10:440-454.
50. Watanabe S., Umehara H., Murayama K., Okabe M., Kimura T., Nakano T. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 2006, 25:2697-2707.
51. Wei F., Schöler H.R., Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 2007, 282:21551-21560.
52. Wei Z., Yang Y., Zhang P., Andrianakos R., Hasegawa K., Lyu J., Chen X., Bai G., Liu C., Pera M., Lu W. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells 2009, 27:2969-2978.
53. Wu Z., Zhang W., Chen G., Cheng L., Liao J., Jia N., Gao Y., Dai H., Yuan J., Cheng L., Xiao L. Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells. J. Biol. Chem. 2008, 283:24991-25002.
54. Xu H., Wang W., Li C., Yu H., Yang A., Wang B., Jin Y. WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells. Cell Res. 2009, 19:561-573.
55. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.